The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Association of Selective and Conventional Nonsteroidal Antiinflammatory Drugs with Acute Renal Failure: A Population-based, Nested Case-Control Analysis
Open accessAbstract
Conventional nonsteroidal antiinflammatory drugs (NSAIDs) are associated with acute renal failure, but cyclooxygenase-2 inhibitors have not been comparatively evaluated. The authors conducted a nested case-control study to assess the association between exposure to NSAIDs, including cyclooxygenase-2 inhibitors, and hospitalization for acute renal failure. They identified 121,722 new NSAID users older than age 65 years from the administrative health care databases of Quebec, Canada, in 1999-2002. Data for 4,228 cases and 84,540 controls matched on age and follow-up time were analyzed by using conditional logistic regression, adjusted for sex, age, health status, health care utilization measures, exposure to contrast agents, and nephrotoxic medications. The risk of acute renal failure for all NSAIDs combined was highest within 30 days of treatment initiation (adjusted rate ratio (RR) = 2.05, 95% confidence interval (CI): 1.61, 2.60) and receded thereafter. The association with acute renal failure within 30 days of therapy initiation was comparable for rofecoxib (RR = 2.31, 95% CI: 1.73, 3.08), naproxen (RR = 2.42, 95% CI: 1.52, 3.85), and nonselective, non-naproxen NSAIDs (RR = 2.30, 95% CI: 1.60, 3.32) but was borderline lower for celecoxib (RR =1.54, 95% CI: 1.14, 2.09; test for interaction comparing celecoxib with rofecoxib, p = 0.057). There was a significant association for both selective and nonselective NSAIDs with acute renal failure, but confirmatory studies are required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,027
Interaction revisited: the difference between two estimates.
Altman, D. G., & Bland, J. M. (2003) · BMJ · doi:10.1136/bmj.326.7382.219 · Cited by 3,203
Silverstein, F. E., Faich, G., Goldstein, J. L., Simon, L. S., Pincus, T., Whelton, A., Makuch, R., Eisen, G., Agrawal, N. M., Stenson, W. F., et al. (2000) · JAMA · doi:10.1001/jama.284.10.1247 · Cited by 3,154
Evaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646
The Coxibs, Selective Inhibitors of Cyclooxygenase-2
FitzGerald, G. A., & Patrono, C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108093450607 · Cited by 1,565
- Statistical Models for Epidemiology
(2013) · Bayesian Methods in Epidemiology · doi:10.1201/b15382-9 · Cited by 1,346
Renal Syndromes Associated with Nonsteroidal Antiinflammatory Drugs
Clive, D. M., & Stoff, J. S. (1984) · New England Journal of Medicine · doi:10.1056/nejm198403013100905 · Cited by 1,122
A chronic disease score from automated pharmacy data
Von Korff, M., Wagner, E. H., & Saunders, K. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90016-g · Cited by 961
Graham, D. J., Campen, D., Hui, R., Spence, M., Cheetham, C., Levy, G., Shoor, S., & Ray, W. A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17864-7 · Cited by 913
Schneeweiss, S. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.9.854 · Cited by 711
Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic
Warner, T. D., & Mitchell, J. A. (2004) · The FASEB Journal · doi:10.1096/fj.03-0645rev · Cited by 614
Tamblyn, R., Lavoie, G., Petrella, L., & Monette, J. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)00234-h · Cited by 577
Solomon, D. H., Schneeweiss, S., Glynn, R. J., Kiyota, Y., Levin, R., Mogun, H., & Avorn, J. (2004) · Circulation · doi:10.1161/01.cir.0000127578.21885.3e · Cited by 509
Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population
Huerta, C., Castellsague, J., Varas-Lorenzo, C., & García Rodríguez, L. A. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.12.005 · Cited by 337
Brenner, B. M. (1996) · Cited by 330
Whelton, A., White, W. B., Bello, A. E., Puma, J. A., & Fort, J. G. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02661-9 · Cited by 310
Nonsteroidal Anti‐Inflammatory Drugs: Effects on Kidney Function
Whelton, A., & Hamilton, C. W. (1991) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1991.tb03743.x · Cited by 282
Nonsteroidal Antiinflammatory Drugs and Acute Renal Failure in Elderly Persons
Griffin, M. R., Yared, A., & Ray, W. A. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010234 · Cited by 271
Nonsteroidal anti-inflammatory drugs: Effects on kidney function
Whelton, A., & Watson, A. J. (1998) · Clinical Nephrotoxins · doi:10.1007/978-94-015-9088-4_14 · Cited by 261
Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research
Yola, M., & Lucien, A. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90170-8 · Cited by 253
Ombardier, C. L. B., Aine, L. O. L., Eicin, A. L. R., Hapiro, D. E. S., Urgos, R. U. B., Avis, B. A. D., Ay, R., Arcos, M. J., Erraz, B. O. F., Awkey, C. H. J. H., et al. (2010) · Cited by 253
Lévesque, L. E., Brophy, J. M., & Zhang, B. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-7-200504050-00113 · Cited by 249
Self-citationGambaro, G., & Perazella, M. A. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01146.x · Cited by 225
Patients Exposed to Rofecoxib and Celecoxib Have Different Odds of Nonfatal Myocardial Infarction
Kimmel, S. E., Berlin, J. A., Reilly, M., Jaskowiak, J., Kishel, L., Chittams, J., & Strom, B. L. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-3-200502010-00005 · Cited by 222
Association of Inhaled Corticosteroid Use With Cataract Extraction in Elderly Patients
Garbe, E. (1998) · JAMA · doi:10.1001/jama.280.6.539 · Cited by 201
Are selective COX-2 inhibitors nephrotoxic?
Perazella, M. A., & Eras, J. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70266-6 · Cited by 171
Nonsteroidal Anti-inflammatory Drugs and the Risk of Hospitalization for Acute Renal Failure
Perez‐Gutthann, S. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440200041005 · Cited by 163
Perazella, M. A., & Tray, K. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00757-4 · Cited by 158
Cyclooxygenase-2 inhibition and renal physiology
Harris, R. C. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02232-4 · Cited by 132
Anti-inflammatory agents and renal function☆, ☆☆
Brater, D. C. (2002) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2002.37216 · Cited by 118
Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure
Perez‐Gutthann, S. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.21.2433 · Cited by 112
Renal Failure Associated with the Use of Celecoxib and Rofecoxib
Ahmad, S. R., Kortepeter, C. M., Brinker, A. D., Chen, M., & Beitz, J. G. (2002) · Drug Safety · doi:10.2165/00002018-200225070-00007 · Cited by 111
Zhao, S. Z., Reynolds, M. W., Lejkowith, J., Whelton, A., & Arellano, F. M. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80121-1 · Cited by 110
Non-steroidal anti-inflammatory drugs and hospitalization for acute renal failure
EVANS, J. M. M., McGregor, E., Mcmahon, A., et al. (1995) · QJM · doi:10.1093/oxfordjournals.qjmed.a069100 · Cited by 100
Novel Approaches to Pharmacoepidemiology Study Design and Statistical Analysis
Suissa, S. (2000) · Pharmacoepidemiology · doi:10.1002/0470842555.ch44 · Cited by 97
Solomon, D. H., Schneeweiß, S., Glynn, R. J., Levin, R., & Avorn, J. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.08.025 · Cited by 83
Meyler's side effects of drugs : an encyclopedia of adverse reactions and interactions
Meyler, L., & Dukes, M. N. G. (1980) · Elsevier eBooks · Cited by 66
Raising the Safety Bar — The FDA's Coxib Meeting
Okie, S. (2005) · New England Journal of Medicine · doi:10.1056/nejmp058055 · Cited by 56
Cyclo-Oxygenase-2 Inhibitors and the Kidney
Noroian, G., & Clive, D. M. (2002) · Drug Safety · doi:10.2165/00002018-200225030-00003 · Cited by 36
Quach, C., Collet, J., & LeLorier, J. (2004) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.991 · Cited by 16
Cited by
Acute kidney injury-epidemiology, outcomes and economics
Rewa, O., & Bagshaw, S. M. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.282 · Cited by 734
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
Kimura, K., Kimura, T., Ishihara, M., Nakagawa, Y., Nakao, K., Miyauchi, K., Sakamoto, T., Tsujita, K., Hagiwara, N., Miyazaki, S., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0133 · Cited by 565
Lapi, F., Azoulay, L., Yin, H., Nessim, S. J., & Suissa, S. (2013) · BMJ · doi:10.1136/bmj.e8525 · Cited by 393
Nonsteroidal Anti-Inflammatory Drugs: Adverse Effects and Their Prevention
Vonkeman, H. E., & van de Laar, M. A. F. J. (2010) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.08.001 · Cited by 365
Ungprasert, P., Cheungpasitporn, W., Crowson, C. S., & Matteson, E. L. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.03.008 · Cited by 322
Metadata
- Authors
- Schneider, V., Lévesque, L. E., Zhang, B., Hutchinson, T., & Brophy, J. M.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-09-27
- Volume
- 164
- Issue
- 9
- Pages
- 881-889
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2114293661
- Cited by
- 270
- References
- 41
- FWCI
- 6.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.